DMAA

Getty Images

From the Editor's Desk

'Edgy' sports nutrition formulas cast a long and deep ethical shadow

By Hank Schultz

Temptation is a fact of human nature, and is an element in the sports nutrition game as well. Some sports products seem ever to edge toward an ethical line, spurred on by the demand from their consumer constituencies for ‘edgy’ formulations.

FDA uses warning letter to check up on DMAA recall

FDA uses warning letter to check up on DMAA recall

By Hank Schultz

In an unusual move, in a warning letter to a dietary supplement company the Food and Drug Administration has sought information about a recall, in this case one involving DMAA products.

PEAs harder to control than were steroids, experts say

PEAs harder to control than were steroids, experts say

By Hank Schultz

The presence and proliferation of phenylethylamines in sports nutrition products continues to be a thorn in the side of the dietary supplement industry.  But trying to regulate these ingredients away is not nearly as straightforward as was the case with...

AMA warns members about rise of nootropics

AMA warns members about rise of nootropics

By Hank Schultz

A new policy by the American Medical Association on nootropics once again highlights the blurred edges of what can legitimately be called a ‘dietary supplement.’

DMBA is being used to replace the banned stimulant DMAA, which has been linked to cases of cerebral haemorrhage, stroke and death

The new DMAA: DMBA warnings spread to EU

By Annie Harrison-Dunn

The Swedish Food Safety Authority (NFA) has urged consumers not to buy products containing DMBA – a novel substance used to replace the banned stimulant DMAA.

Offside! ESSNA blows whistle on athletes’ doping excuses

Special edition: Sports nutrition

Offside! ESSNA blows whistle on athletes’ doping excuses

By Shane STARLING

Europe’s sports nutrition sector today launched a stinging attack on elite athletes who blame doping infringements on contaminated sports supplements as happened multiple times at the recent Winter Olympiad in Sochi, Russia.

The ten most important news of the year

The ten most important news of the year

Every day, NutraIngredients-USA brings you the latest industry news and developments, insights from thought leaders, and cutting edge science. That makes for a lot of information to help you make the best decisions for your business. Of course, some news...

More DMAA products come off market

More DMAA products come off market

By Hank Schultz

Beta Labs, a dietary supplements distributor and retailer, has recalled four sports supplement products that contain DMAA. The company said it initiated the recall after “a review of recent FDA communications related to 1,3 dimethylamylamine (DMAA).”

One more time: US Army/ NSF analysis shows DMAA not in geranium

One more time: US Army/ NSF analysis shows DMAA not in geranium

By Stephen DANIELLS

A new analysis from US Army scientists and NSF International finds, yet again, that controversial compound DMAA (1,3 dimethylamylamine) is not found in geranium. The analysis supports FDA conclusions that the evidence is ‘insufficient’ to support the...

FDA: 'Information is insufficient to defend the use of DMAA'

Updated: CRN calls on industry to stop manufacturing DMAA-containing products

FDA: 'Information is insufficient to defend the use of DMAA'

By Stephen DANIELLS

After reviewing the response from USPlabs about the use of DMAA as an ingredient in dietary supplements, the FDA has concluded that the evidence is ‘insufficient’, NutraIngredients-USA can report.

CRN opposes ‘inappropriate’ NY DMAA ban proposal

CRN opposes ‘inappropriate’ NY DMAA ban proposal

By Stephen Daniells

New York State Senate Majority Coalition Leader Jeff Klein is seeking to ban the sale of products containing the controversial ingredient DMAA (dimethylamylamine) in the Empire State.

ABC article puts another nail in DMAA's coffin

ABC article puts another nail in DMAA's coffin

By Hank Schultz

The studies that claim to have found DMAA present in geranium are suspect both because of where they were published–in an open-access, pay-for-publication journal–and because of problems with the studies themselves, a new article by the American Botanical...

Follow us

Products

View more

Webinars